Literature DB >> 23223809

[Resection plus adjuvant chemotherapy improves survival in advanced pancreatic adenocarcinoma].

S E Combs1, J Werner.   

Abstract

Entities:  

Year:  2013        PMID： 23223809     DOI： 10.1007/s00066-012-0268-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  15 in total

1.  Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Authors:  Helmut Oettle; Stefan Post; Peter Neuhaus; Klaus Gellert; Jan Langrehr; Karsten Ridwelski; Harald Schramm; Joerg Fahlke; Carl Zuelke; Christof Burkart; Klaus Gutberlet; Erika Kettner; Harald Schmalenberg; Karin Weigang-Koehler; Wolf-Otto Bechstein; Marco Niedergethmann; Ingo Schmidt-Wolf; Lars Roll; Bernd Doerken; Hanno Riess
Journal:  JAMA       Date:  2007-01-17       Impact factor: 56.272

2.  [S3-Guidelines "Exocrine pancreatic cancer" 2007].

Authors:  G Adler; T Seufferlein; S C Bischoff; H-J Brambs; S Feuerbach; G Grabenbauer; S Hahn; V Heinemann; W Hohenberger; J M Langrehr; M P Lutz; O Micke; H Neuhaus; P Neuhaus; H Oettle; P M Schlag; R Schmid; W Schmiegel; K Schlottmann; J Werner; B Wiedenmann; I Kopp
Journal:  Z Gastroenterol       Date:  2007-06       Impact factor: 2.000

Review 3.  A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer.

Authors:  Alessio G Morganti; Mariangela Massaccesi; Giuseppe La Torre; Luciana Caravatta; Adele Piscopo; Rosa Tambaro; Luigi Sofo; Giuseppina Sallustio; Marcello Ingrosso; Gabriella Macchia; Francesco Deodato; Vincenzo Picardi; Edy Ippolito; Numa Cellini; Vincenzo Valentini
Journal:  Ann Surg Oncol       Date:  2009-10-24       Impact factor: 5.344

4.  Prognosis of resected pancreatic cancer: is the refined resection margin status dispensable?

Authors:  Werner Hartwig; Jens Werner; Markus W Büchler
Journal:  Langenbecks Arch Surg       Date:  2012-07-21       Impact factor: 3.445

5.  Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.

Authors:  J H Klinkenbijl; J Jeekel; T Sahmoud; R van Pel; M L Couvreur; C H Veenhof; J P Arnaud; D G Gonzalez; L T de Wit; A Hennipman; J Wils
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

Review 6.  Adjuvant chemotherapy, with or without postoperative radiotherapy, for resectable advanced pancreatic adenocarcinoma: continue or stop?

Authors:  Fang Ren; Ying-Chun Xu; Hong-Xia Wang; Lei Tang; Yue Ma
Journal:  Pancreatology       Date:  2012-02-08       Impact factor: 3.996

Review 7.  Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages.

Authors:  Sonja Gillen; Tibor Schuster; Christian Meyer Zum Büschenfelde; Helmut Friess; Jörg Kleeff
Journal:  PLoS Med       Date:  2010-04-20       Impact factor: 11.069

Review 8.  Postoperative adjuvant therapy for pancreatic cancer.

Authors:  David R Penberthy; Tyvin A Rich; Reid B Adams
Journal:  Semin Surg Oncol       Date:  2003

9.  Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

Authors:  Daniel Habermehl; Kerstin Kessel; Thomas Welzel; Holger Hof; Amir Abdollahi; Frank Bergmann; Stefan Rieken; Jürgen Weitz; Jens Werner; Peter Schirmacher; Markus W Büchler; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2012-03-02       Impact factor: 3.481

10.  Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.

Authors:  D D Stocken; M W Büchler; C Dervenis; C Bassi; H Jeekel; J H G Klinkenbijl; K E Bakkevold; T Takada; H Amano; J P Neoptolemos
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640
View more
  1 in total

1.  Outcome after neoadjuvant chemoradiation and correlation with nutritional status in patients with locally advanced pancreatic cancer.

Authors:  P Naumann; D Habermehl; T Welzel; J Debus; S E Combs
Journal:  Strahlenther Onkol       Date:  2013-07-31       Impact factor: 3.621
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.